Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 342 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/6/2007


1.		Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				SWOG-7841

Last Modified: 5/23/2007


2.		Phase II/III Chemotherapy with MVP (MITO/VBL/CACP) vs CHIP vs CBDCA vs VBL/CACP vs MVP-CAMP (MITO/VBL/CACP/CTX/ADR/MTX/PCB) in Patients with Metastatic (Stage III) non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-1583 EST-1583


3.		Phase II/III Comparison of FAM (5-FU/ADR/MITO) vs Sequential MITO, ADR, and 5-FU for Hormone-Refractory Carcinoma of the Prostate (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				NCCTG-825251 NCCTG-82-52-51

Last Modified: 9/25/2007


4.		Phase III Chemotherapy with FAM-S (5-FU/ADR/MITO/SZC) vs a Phase II Drug for Locally Inoperable or Metastatic Pancreatic Adenocarcinoma, a Master Protocol

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 70				NCI				SWOG-8040


5.		Phase II/III Randomized Comparison of PF (CACP/5-FU) vs MVPF (MITO/VCR/CACP/5-FU) in Advanced Large Bowel Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-1285 EST-1285

Last Modified: 4/1/1988


6.		Phase II/III Randomized Trial of Chemotherapy with FAMTX (5-FU/ADR/MTX) vs FAM (5-FU/ADR/MITO) in Patients with Metastatic Gastric Cancer (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				70 and under								EORTC-40851


7.		Phase II/III Randomized Trial of Immunotherapy with MoAb 17-1A Given Before vs After Chemotherapy with FAM (5-FU/ADR/MITO-C) in Patients with Advanced Pancreatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								FCCC-85719 NCI-V85-0077

Last Modified: 6/1/1988


8.		Phase II/III Study of Intravesical Chemotherapy with Mitomycin-C in Patients with Multiple Lesions of Superficial Bladder Cancer (Summary Last Modified 06/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				85 and under								EORTC-30864


9.		Phase II/III Chemotherapy with Combinations of MeCCNU, MITO, ADR and 5-FU for Advanced Measurable Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-2277

Last Modified: 5/22/2007


10.		Phase II-III Study of Chemotherapy with ADR or 5-FU/MeCCNU or 5-FU/Mitomycin C for Advanced Gastric Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-3274 MAYO-706018

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute